Clear cell carcinoma of the uterine cervix: Pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol

Gynecologic Oncology

Volumn 76, Issue 3, 2000, Pages 331-335

  Reich, Olaf ^a   Tamussino, Karl ^a   Lahousen, Manfred ^a   Pickel, Hellmuth ^a   Haas, Josef ^a   Winter, Raimund ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; FEMALE; HUMAN; PATHOGENESIS; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

EID: 0034014357     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5700     Document Type: Article

References (39)

1. Matias-Guiu X, Lerma E, Prat J. Clear cell tumors of the female genital tract. Semin Diagn Pathol. 14:1997;233-239.
2. Kudo R. Cervical adenocarcinoma. Sasano N. Gynecological Tumors - Recent Progress in Diagnostic Pathology. 1992;81-108 Springer-Verlag, Berlin.
3. Dallenbach-Hellweg G, Lang G. Immunohistochemical studies on uterine tumors. Pathol Res Pract. 187:1991;36-43.
4. Boyd J, Takahashi H, Waggoner S E, Jones L A, Hajek R A, Wharton J T, Liu F S, Fujino T, Barret J C, McLachlan J A. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero. Cancer. 77:1996;507-513.
5. Resnik E, Christopherson W A, Stock R. Clear cell adenocarcinoma of the cervix and vagina in a woman with mixed gonadal dysgenesis: A case report. J Reprod Med. 34:1989;981-984.
6. Hanselaar A, van Loosbroek M, Schuurbiers O, Helmerhost T, Bulten J, Bernheim J. Clear cell adenocarcinoma of the vagina and cervix: An update of the central Netherlands registry showing twin age incidence peaks. Cancer. 79:1997;2229-2236.
7. Waggoner S E, Anderson S M, Luce M C, Takahashi H, Boyd J. p53 protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix. Gynecol Oncol. 60:1996;339-344.
8. Fujiwara H, Mitchell M F, Arseneau J, Hale R J, Wright T C. Clear cell adenosquamous carcinoma of the cervix: An aggressive tumor associated with human papillomavirus 18. Cancer. 9:1995;1591-1600.
9. Waggoner S E, Baunoch D A, Anderson S A, Leigh F, Zagaja V G. Bcl-2 protein expression associated with resistance to apoptosis in clear cell adenocarcinomas of the vagina and cervix expressing wild-type p53. Ann Surg Oncol. 5:1998;544-547.
10. Waggoner S E, Anderson S M, Van Eyck S, Fuller J, Luce M C, Herbst A L. Human papillomavirus detection and p53 expression in clear cell adenocarcinoma of the vagina and cervix. Obstet Gynecol. 84:1994;404-408.
11. Robboy S J, Herbst A L, Scully R E. Clear cell adenocarcinoma of the vagina and cervix in young females: Analysis of 37 tumors that persisted or recurred after primary therapy. Cancer. 24:1974;606-614.
12. Herbst A L, Norusis M J, Rosenow P J, Welch R R, Scully R E. An analysis of 346 cases of clear cell adenocarcinoma of the vagina and cervix with emphasis on recurrence and survival. Gynecol Oncol. 7:1979;111-122.
13. Kaminiski P F, Maier R C. Clear cell carcinoma of the cervix unrelated to diethylstilbestrol exposure. Obstet Gynecol. 62:1983;720-727.
14. Fawcett K J, Dockerty M B, Hunt A B. Mesonephric carcinomas and adenocarcinomas of the cervix in children. J Pediatr. 69:1966;104-110.
15. Hart W R, Norris H J. Mesonephric adenocarcinomas of the cervix. Cancer. 9:1972;106-113.
16. Noller K L, Decker G G, Dockerty M B, Lanier A P, Smith R A, Symmonds R E. Mesonephric (clear cell) carcinoma of the vagina and cervix: A retrospective analysis. Obstet Gynecol. 43:1974;640-644.
17. Saigo P E, Cain J M, Kim W S, Gaynor J J, Johnson K, Lewis J L. Prognostic factors in adenocarcinoma of the uterine cervix. Cancer. 57:1986;1584-1593.
18. Scully, R, E, Bonfiglio, T, A, Kurman, R, J, Silverberg, S, G, Wilkinson, E, J, Histological Typing of Female Genital Tract Tumors. Berlin, Springer-Verlag, 1998.
19. Christopherson W M, Alberhasky R C, Connelly P J. Carcinoma of the endometrium: A clinicopathologic study of clear cell adenocarcinoma and secretory carcinoma. Cancer. 49:1982;1511-1523.
20. Winter R. Lymphadenectomy. Burghardt E, Webb M J, Monaghan J M, Kindermann G. Surgical Gynecologic Oncology. 1993;282-289 Thieme, Stuttgart.
21. Pickel H. Methods of Oncology - Histopathology. Burghardt E, Webb M J, Monaghan J M, Kindermann G. Surgical Gynecologic Oncology. 1993;11-14 Thieme, Stuttgart.
22. Girardi F, Haas J. The importance of histologic processing of pelvic lymph nodes in the treatment of cervical cancer. Int J Gynecol Cancer. 3:1993;12-17.
23. Goehde W, Schumann J, Zaute J. The use of DAPI in pulse cytophotometry. Lutz D. Pulse Cytophotometry. 1978;229-232 European Press, Gent.
24. Wesolwski J A, Adelson M D. Therapeutic considerations in an 8-year-old girl with clear cell adenocarcinoma of the cervix. J Gynecol Surg. 13:1997;31-34.
25. Seseke F, Kugler A, Hammerlein B, Gross A J, Ringert R H. Metastasis from renal cell carcinoma to the uterine cervix. Scand J Urol Nephrol. 32:1998;290-292.
26. Mitani Y, Jimi S, Iwasaki H. Carcinomatous infiltration into the uterine body in carcinoma of the uterine cervix. Am J Obstet Gynecol. 89:1964;984-987.
27. Abeler V W, Kjorstad K E. Clear cell carcinoma of the endometrium: A histopathological and clinical study of 97 cases. Gynecol Oncol. 40:1991;207-217.
28. Burghardt E. Cervical Cancer. Burghardt E, Webb M J, Monagham J M, Kindermann G. Surgical Gynecologic Oncology. 1993;188-322 Thieme, Stuttgart.
29. Friedell G H, Parsons L. The spread of cancer of the uterine cervix as seen in giant histological sections. Cancer. 14:1961;42-54.
30. Lasersohn J T, Thomas L B, Smith R R, Ketcham A S, Dillon J S. Carcinoma of the uterine cervix: A study of surgical, pathological, and autopsy findings. Cancer. 17:1964;338-351.
31. Shingleton H M, Orr J W. Cancer of the Cervix: Diagnosis and Treatment. 1987;Churchill Livingstone, Edinburgh.
32. Tabata M, Ichinoe K, Sakuragi N, Shiina Y, Yamaguchi T, Mabuchi Y. Incidence of ovarian metastasis in patients with cancer of the uterine cervix. Gynecol Oncol. 28:1987;255-261.
33. Jones W B, Tan L K, Lewis J L. Late recurrence of clear cell adenocarcinoma of the vagina and cervix: A report of three cases. Gynecol Oncol. 51:1993;266-271.
34. Burks R T, Schwarz A M, Wheeler J E, Antonioli D. Late recurrence of clear cell adenocarcinoma of the cervix: A case report. Obstet Gynecol. 76:1990;525-527.
35. Hurt W G, Silverberg S G, Frable W J, Belgrad R, Crooks L D. Adenocarcinoma of the cervix: Histopathologic and clinical features. Am J Obstet Gynecol. 129:1977;304-315.
36. Fu Y W, Reagan J W, Fu A S, Janiga K E. Adenocarcinoma and mixed carcinoma of the the uterine cervix: 2. Prognostic value of nuclear DNA analysis. Cancer. 49:1982;2571-2577.
37. Leminen A, Paavonen J, Vesterinen E, Forss M, Wahlstrom T, Kulomaa P. Desoxyribonucleic acid flow cytometric analysis of cervical adenocarcinomas: Prognostic significance of desoxyribonucleic acid ploidy and S-phase fraction. Am J Obstet Gynecol. 102:1990;848-853.
38. Noller K L, Decker D G, Symmonds R E, Dockerty M B, Kurland L T. Clear cell adenocarcinoma of the vagina and cervix: survival data. Am J Obstet Gynecol. 124:1976;285-288.
39. Tenti P, Romagnoli S, Silini E, Pellafgata N S, Zappatore R, Spinillo A. Analysis and clinical implications of K-ras gene mutations and infection with human papillomavirus type 16 and 18 in primary adenocarcinoma of the uterine cervix. Int J Cancer. 64:1995;9-13.